Andy Widger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andy widger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andy Widger Today - Breaking & Trending Today

Weekly column by East Devon District Council leader Paul Arnott

I’m not sure where “it’s not the winning, it’s the taking part that matters” comes from. So, I googled, and nobody else is sure either. ....

United Kingdom , City Of , Andy Widger , Michael Gove , Sarina Weigman , Tian Richards , Department Of Education , World Cup , Stony Love , Ottery St Mary ,

BioNTech SE: Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY in the EU to Adolescents

BioNTech SE: Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY in the EU to Adolescents
1
(Nasdaq: BNTX) today announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in the European Union (EU) to the European Medicines Agency (EMA) for the Pfizer-BioNTech vaccine COMIRNATY
(BNT162b2) to request an extension of the indication for use in adolescents 12 to 15 years of age. If EMA approves the variation, the amended CMA will be valid in all 27 member states of the EU. The companies have already submitted a similar request to the U.S. Food and Drug Administration (FDA) for the Emergency Use Authorization (EUA) and plan to request additional amendments with other regulatory authorities worldwide. ....

United States , United Kingdom , Sylke Maas , Andy Widger , Chuck Triano , Fosun Pharma , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , European Union , European Medicines Agency , Roche Group , Conditional Marketing Authorization , Emergency Use Authorization , Marketing Authorization Holder , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Pfizer News , Biologics License Application , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act ,

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Andy Widger , Albert Bourla , Relationssylke Maas , Relationsjasmina Alatovic , Sean Marett , Relationschuck Triano , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Wall Street , Advanced Purchase Agreement , Chief Executive Officer , Chief Business , Chief Commercial Officer , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Pfizer News , Biologics License Application , Annual Report , Looking Information ,

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
News Provided By
Share This Article
®, bringing total doses to 600 million for 27 EU member states
All doses expected to be delivered in 2021
BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY
®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced Purchase Agreement signed on
1. This brings the total number of doses to be delivered to the EU to 600 million. ....

Andy Widger , Sylke Maas , Albert Bourla , Chuck Triano , Sean Marett , Fosun Pharma , Biontech To Supply The European Union , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , European Medicines Agency , Roche Group , Advanced Purchase Agreement , Chief Executive Officer , Chief Business , Chief Commercial Officer , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Biologics License Application , Annual Report , Looking Information , Factors That May Affect Future , New Technologies ,

Britain asks regulator to assess Pfizer vaccine for suitability

3 Min Read
LONDON (Reuters) - Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.
Slideshow ( 2 images )
Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.3 million worldwide and crippled the global economy.
Britain’s health minister, Matt Hancock, said the government had taken the step after the two companies applied for emergency use authorisation in the United States.
“That has given us the confidence . formally to start the process here,” he told a news conference. ....

United Kingdom , New York , United States , City Of , Matt Hancock , Andy Widger , Elizabeth Piper , Matthew Lewis , Carl Odonnell , Stephen Addison , Kate Holton , Kirsten Donovan , Jonathan Van Tam , Thomson Reuters Trust Principles , National Health Service , Van Tam , Carlo Donnell , Thomson Reuters Trust , Corona Virus , Asia Pacific , Corporate Events , Bio Therapeutic Drugs Trbc Level 5 , Biopharmaceuticals Trbc Level 5 , Central Eastern Europe , Company News , China Prc ,